| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/10/2006 | US7119166 Universal procedure for refolding recombinant proteins |
| 10/10/2006 | US7119165 Nogo receptor-mediated blockade of axonal growth |
| 10/10/2006 | US7119078 Administering a G-rich oligonucleotide that forms a G-quartet structure and inhibits DNA binding activity of a signal transducer and activator of transcription 3 (STAT3) protein; antiproliferative, anticarcinogenic, antitumor agents |
| 10/10/2006 | US7118924 Severe combined immunodeficiency disease (SCID); immunotherapy of human diseases such as prostate cancer |
| 10/10/2006 | US7118902 modified aggrecanases, nucleotides encoding such enzymes, and processes for producing these enzymes with improved stability; treatment of osteoarthritis |
| 10/10/2006 | US7118890 Antibodies to vertebrate delta proteins and fragments |
| 10/10/2006 | US7118888 Gene expression vaccine |
| 10/10/2006 | US7118885 Nucleic acid encoding vitamin D receptor related polypeptide |
| 10/10/2006 | US7118874 Generation of immunogenic peptide mixture; obtain immunogenic eptitope sequences of a parasite, determine amino acid sequences, synthesizing peptide mixture, recover peptides |
| 10/10/2006 | US7118853 Providing tumor sample; Detecting expression or activity of a gene encoding the polypeptide in tumor sample; classifying the tumor as belonging to a tumor subclass |
| 10/10/2006 | US7118769 For therapy of illnesses of the cardio-vascular system |
| 10/10/2006 | US7118758 antigens that stimulate protective antibodies against enterotoxigenic Escherichia coli; proteins encoded by cssA and cssB genes |
| 10/10/2006 | US7118757 Meningococcal class 1 outer-membrane protein vaccine |
| 10/10/2006 | US7118756 Recombinant protective protein from Streptococcus pneumoniae |
| 10/10/2006 | US7118755 Herpes viruses for immune modulation |
| 10/10/2006 | US7118754 Pharmaceutical composition for treating papillomavirus tumors and infection |
| 10/10/2006 | US7118753 Enhancing cell-based immunotherapy |
| 10/10/2006 | US7118752 Administering to one or more malignant cells an effective amount of a peptide species comprising an E-domain of insulin-like growth factor I (IGF-I) |
| 10/10/2006 | US7118751 DNA vaccines encoding antigen linked to a domain that binds CD40 |
| 10/10/2006 | US7118750 Modified TNF-alpha molecules, DNA encoding such and vaccines comprising such modified TNF-alpha and DNA |
| 10/10/2006 | US7118749 Transferrin receptor genes |
| 10/10/2006 | US7118748 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 10/10/2006 | US7118747 AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents |
| 10/10/2006 | US7118745 covalent bond between the chelate and the antibody prevents the rapid dissociation of the chelate-antibody complex and greatly improves the in vivo residence times of the chelate |
| 10/10/2006 | US7118744 Immunogenic compositions for induction of anti-tumor immunity |
| 10/10/2006 | US7118743 Bispecific molecules cross-linking ITIM and ITAM for therapy |
| 10/10/2006 | US7118742 Ligand for herpes simplex virus entry mediator and methods of use |
| 10/10/2006 | US7118741 synthetic bi-functional or cross-linker protein which is capable of binding to a molecular species, particularly a macromolecule such as an antibody; having a binding region capable of binding the to transcytosis receptors present in epithelial cells (such a mucosal cells) |
| 10/10/2006 | US7118738 Recombinant pox virus for immunization against MUC1 tumor-associated antigen |
| 10/10/2006 | CA2212887C Monoclonal antibody specific for .beta.a4 peptide |
| 10/10/2006 | CA2208849C Novel cyclodextrin derivatives and methods for the preparation thereof |
| 10/08/2006 | CA2540736A1 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof |
| 10/08/2006 | CA2503932A1 Polypeptides of leishmania major and polynucleotides encoding same and vaccinal, therapeutical and diagnostic applications thereof |
| 10/05/2006 | WO2006105538A2 Methods and compositions for treating il-21 related pathologies |
| 10/05/2006 | WO2006105479A2 Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases |
| 10/05/2006 | WO2006105168A2 Enhancing immune responses with bacterial exotoxins |
| 10/05/2006 | WO2006105062A2 Altered antibody fc regions and uses thereof |
| 10/05/2006 | WO2006105044A1 Suicidal mutant leishmania vaccine |
| 10/05/2006 | WO2006104989A2 Altered antibody fc regions and uses thereof |
| 10/05/2006 | WO2006104890A2 Vaccines against chlamydial infection |
| 10/05/2006 | WO2006104677A2 Antibodies that bind ov064 and methods of use therefor |
| 10/05/2006 | WO2006104615A2 Influenza nucleic acids, polypeptides, and uses thereof |
| 10/05/2006 | WO2006104389A1 Methods and means for diagnostics, prevention and treatment of mycobacterium infections and tuberculosis disease |
| 10/05/2006 | WO2006104336A1 Composition for prevention, alleviation and treatment of atopyic dermatitis |
| 10/05/2006 | WO2006104199A1 Liposome composition for induction of immunity |
| 10/05/2006 | WO2006104099A1 RORα PROMOTING THE INDUCTION OF Bmal1 EXPRESSION |
| 10/05/2006 | WO2006103562A2 Endogenous retrovirus and proteins encoded by env gene as a target for cancer treatment |
| 10/05/2006 | WO2006103472A2 Soluble vox2 protein as immunoregulatory factor |
| 10/05/2006 | WO2006103343A1 Use of protein 2e9 for in vitro diagnosis of mycoplasma pneumoniae infections |
| 10/05/2006 | WO2006103116A1 Human antibodies with beta-amyloid peptide-binding capacity and their applications |
| 10/05/2006 | WO2006102767A1 Tuberculosis vaccine and method for making same |
| 10/05/2006 | WO2006102716A1 A method of diagnosis and treatment and agents useful for same |
| 10/05/2006 | WO2006102715A1 Methods and agents for modulating cellular activity |
| 10/05/2006 | WO2006091796A3 Compositions and methods for diagnosing and treating retinal diseases |
| 10/05/2006 | WO2006091733A3 Method for enhancing the immune response to staphylococcus aureus infection |
| 10/05/2006 | WO2006073431A9 Avipox recombinants expressing foot and mouth disease virus genes |
| 10/05/2006 | WO2006066049A3 Humanized antibodies that recognize beta amyloid peptide |
| 10/05/2006 | WO2006065553A3 Glycoconjugate vaccines containing peptidoglycan |
| 10/05/2006 | WO2006062716A3 Methods and compositions for treating ocular disorders |
| 10/05/2006 | WO2006059247A3 VACCINES, COMPOSITIONS AND METHODS BASED ON STAPHYLOCOCCUS AUREUS IRON-REGULATED SURFACE DETERMINANTS IsdA, IsdB, and IsdC |
| 10/05/2006 | WO2006052591A3 Anti-properdin antibodies, and methods for making and using same |
| 10/05/2006 | WO2006044045A3 Cryptosporidium hominis genes and gene products for chemotherapeutic, immunoprophylactic and diagnostic applications |
| 10/05/2006 | WO2006034184A3 Use of modulators of a novel form of muscle selective calcineurin interacting protein (mcip-1-38) as a treatment for cardiovascular diseases |
| 10/05/2006 | WO2006026759A3 Humanized anti-beta7 antagonists and uses therefor |
| 10/05/2006 | WO2006026172A3 Use of soluble cd26 as inhibitor of angiogenesis and inflammation |
| 10/05/2006 | WO2006014292A3 Oral vaccine for borrelia |
| 10/05/2006 | WO2006009901A3 Novel antigen-binding polypeptides and their uses |
| 10/05/2006 | WO2006002889A3 Improved adjuvant therapy of g250-expressing tumors |
| 10/05/2006 | WO2005087265A8 Antineoplastic combinations of cci-779 and rituximab |
| 10/05/2006 | WO2005084390A3 Partially loaded antibodies and methods of their conjugation |
| 10/05/2006 | WO2005014778A3 Dna vaccine expressing ha1 of equine-2 influenza virus |
| 10/05/2006 | WO2005002500A3 Inhibitors of coronavirus |
| 10/05/2006 | WO2004064774A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | WO2004044163A3 Methods for identifying risk of melanoma and treatments thereof |
| 10/05/2006 | WO2003106643A8 Novel polynucleotides encoding lamprey gnrh-iii |
| 10/05/2006 | WO2003087761A3 Molecular profiling of disease and therapeutic response using phospho-specific antibodies |
| 10/05/2006 | WO2003087306A8 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 10/05/2006 | US20060223990 Synthesis, deprotection, analysis & purification of RNA & ribozymes |
| 10/05/2006 | US20060223986 Process for selectively isolating IgY antibodies from egg yolk of an anseriform bird and igy antibodies obtained thereby |
| 10/05/2006 | US20060223865 Therapeutic combination |
| 10/05/2006 | US20060223778 Circular nucleic acid vectors, and methods for making and using the same |
| 10/05/2006 | US20060223776 Crosslinking compound releasing drug in acidity environment; for use as vaccines or therapeutic agents |
| 10/05/2006 | US20060223769 Vaccines using nucleic acid-lipid complexes |
| 10/05/2006 | US20060223752 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell |
| 10/05/2006 | US20060223744 Prostate specific antigens and uses thereof |
| 10/05/2006 | US20060223082 Map |
| 10/05/2006 | US20060222667 Apparatus for treating asthma using neurotoxin |
| 10/05/2006 | US20060222666 Clostridial toxin derivatives and methods for treating pain |
| 10/05/2006 | US20060222665 Virus vaccine |
| 10/05/2006 | US20060222664 Transforming tobacco cell line containing sequences encoding antigens (such as hemagglutinin/neuraminidase protein from Newcastle Disease Virus), culturing, washing, suspending in lysis buffer, disrupting cells, then separating debris; vaccines |
| 10/05/2006 | US20060222663 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 10/05/2006 | US20060222662 Composition to be administered to a living being and method for marking agents |
| 10/05/2006 | US20060222661 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 10/05/2006 | US20060222660 Use of DNA vaccine in combination with a conventional vaccine to overcome immunogen interference |
| 10/05/2006 | US20060222659 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 10/05/2006 | US20060222658 Vaccinia virus nucleic acids, polypeptides and immunogenic compositions |
| 10/05/2006 | US20060222657 Polypeptide transduction and fusogenic peptides |
| 10/05/2006 | US20060222656 MAGE-A3/HPV 16 peptide vaccines for head and neck cancer |
| 10/05/2006 | US20060222655 Compositions and methods for preventing and treating endotoxin-related diseases and conditions |